Flux Across of Microneedle-treated Skin is Increased by Increasing Charge of Naltrexone and Naltrexol In Vitro
- 1 May 2008
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 25 (7) , 1677-1685
Abstract
Purpose The purpose of this investigation was to evaluate the in vitro microneedle (MN) enhanced percutaneous absorption of naltrexone hydrochloride salt (NTX·HCl) compared to naltrexone base (NTX) in hairless guinea pig skin (GP) and human abdominal skin. In a second set of experiments, permeability of the major active metabolite 6-β-naltrexol base (NTXOL) in the primarily unionized (unprotonated) form at pH 8.5 was compared to the ionized form (pH 4.5). Methods In vitro fluxes of NTX, NTX·HCl and ionized and unionized NTXOL were measured through microneedle treated or intact full thickness human and GP skin using a flow through diffusion apparatus. Solubility and diffusion samples were analyzed by HPLC. Results Both GP and human skin show significant increases in flux when treated with 100 MN insertions as compared to intact full thickness skin when treated with NTX·HCl or ionized NTXOL (pH 4.5; p < 0.05). MN increased GP skin permeability for the hydrophilic HCL salt of NTX by tenfold and decreased lag time by tenfold too. Similar results were found using human skin, such that skin permeability to NTX·HCl was elevated to 7.0 × 10−5 cm/h. Permeability of the primarily unionized (unprotonated) form of NTXOL at pH 8.5 was increased by MN only threefold and lag time was only modestly reduced. However, MN treatment with the primarily ionized (protonated) form of NTXOL at pH 4.5 increased skin permeability fivefold and decreased lag time fourfold. Conclusion Enhancement was observed in vitro in both GP and human skin treated with MN compared to intact skin with the salt form of NTX and the ionized form of NTXOL. We conclude that transdermal flux can be optimized by using MN in combination with charged (protonated) drugs that have increased solubility in an aqueous patch reservoir and increased permeability through aqueous pathways created by MN in the skin.Keywords
This publication has 22 references indexed in Scilit:
- Transdermal Delivery of Naltrexone and its Active Metabolite 6-β-Naltrexol in Human Skin in Vitro and Guinea Pigs in VivoJournal of Pharmaceutical Sciences, 2005
- Bioconversion of Naltrexone and Its 3-O-Alkyl-Ester Prodrugs in a Human Skin EquivalentJournal of Pharmaceutical Sciences, 2005
- In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigsJournal of Controlled Release, 2005
- In Vitro Release Studies on Matrix Type Transdermal Drug Delivery Systems of Naltrexone and Its Acetyl ProdrugDrug Development and Industrial Pharmacy, 2005
- Transdermal delivery of desmopressin using a coated microneedle array patch systemJournal of Controlled Release, 2004
- Microneedles for transdermal drug deliveryAdvanced Drug Delivery Reviews, 2004
- Current status and future potential of transdermal drug deliveryNature Reviews Drug Discovery, 2004
- Silicon micromachined hollow microneedles for transdermal liquid transportJournal of Microelectromechanical Systems, 2003
- Lack of Pain Associated with Microfabricated MicroneedlesAnesthesia & Analgesia, 2001
- Probes for narcotic receptor mediated phenomena. 18. Epimeric 6.alpha.- and 6.beta.-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5.alpha.-epoxymorphinans as potential ligands for opioid receptor single photon emission computed tomography: synthesis, evaluation, and radiochemistry of [125I]-6.beta.-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5.alpha.-epoxymorphinanJournal of Medicinal Chemistry, 1992